To test the hypothesis that L-DOPA decarboxylase (DDC) is a regulated
enzyme in the synthesis of dopamine (DA), we developed a model of the
cerebral uptake and metabolism of [H-3]DOPA. The unidirectional blood-
brain clearance of [H-3]DOPA (K-1(D)) was 0.049 ml g(-1) min(-1). The
relative DDC activity (k(3)(D)) was 0.26 min(-1) in striatum, 0.04 min
(-1) in hypothalamus, and 0.02 min(-1) in hippocampus. In striatum, 3,
4-[H-3] dihydroxyphenylacetic acid ([H-3] DOPAC) was formed from [H-3]
DA with a rate constant of 0.013 min(-1), [H-3]homovanillic acid ([H-3
]HVA) was formed from [H-3]DOPAC at a rate constant of 0.020 min(-1),
and [H-3]HVA was eliminated from brain at a rate constant of 0.037 min
(-1). Together, these rate constants predicted the ratios of endogenou
s DOPAC and HVA to DA in rat striatum. Pargyline, an inhibitor of DA c
atabolism, substantially reduced the contrast between striatum and cor
tex, in comparison with the contrast seen in autoradiograms of control
rats. At 30 min and at 4 h after pargyline, k(3)(D) was reduced by 50
% in striatum and olfactory tubercle but was unaffected in hypothalamu
s, indicating that DDC activity is reduced in specific brain regions a
fter monoamine oxidase inhibition. Thus, DDC activity may be a regulat
ed step in the synthesis of DA.